Patents by Inventor Yuzi WU

Yuzi WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9849168
    Abstract: Disclosed are an attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof. In the present invention, pathological lung tissues of swine having typical Mycoplasma hyopneumoniae (Mhp) infection and no obvious other pathogenic infections are screened, and subcultured 100 generations in lungs of newborn rabbits; then, Mhp strains are isolated and serially subcultured in a medium; and the Mhp strain AN306 is obtained by screening a plurality of strains, which is deposited with an accession number: CCTCC NO. M2012431. Also disclosed is a live vaccine formulation against MPS prepared on the basis of the attenuated strain and comprising live attenuated strain, a pharmaceutically acceptable carrier or excipient, and optionally an adjuvant and immunogens of other pathogens.
    Type: Grant
    Filed: January 26, 2014
    Date of Patent: December 26, 2017
    Assignee: JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Guoqinq Shao, Qiyan Xiong, Maojun Liu, Zhixin Feng, Yanna Wei, Haiyan Wang, Fangfang Bai, Yuan Gan, Li Wang, Daohua Zhang, Dongxia Liu, Lizhong Hua, Yuzi Wu, Yun Bai, Zhanwei Wang
  • Publication number: 20160346372
    Abstract: Disclosed are an attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof. In the present invention, pathological lung tissues of swine having typical Mycoplasma hyopneumoniae (Mhp) infection and no obvious other pathogenic infections are screened, and subcultured 100 generations in lungs of newborn rabbits; then, Mhp strains are isolated and serially subcultured in a medium; and the Mhp strain AN306 is obtained by screening a plurality of strains, which is deposited with an accession number: CCTCC NO. M2014176. Also disclosed is a live vaccine formulation against MPS prepared on the basis of the attenuated strain and comprising live attenuated strain, a pharmaceutically acceptable carrier or excipient, and optionally an adjuvant and immunogens of other pathogens.
    Type: Application
    Filed: January 26, 2014
    Publication date: December 1, 2016
    Applicant: JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Guoqinq SHAO, Qiyan XIONG, Maojun LIU, Zhixin FENG, Yanna WEI, Haiyan WANG, Fangfang BAI, Yuan GAN, Li WANG, Daohua ZHANG, Dongxia LIU, Lizhong HUA, Yuzi WU, Yun BAI, Zhanwei WANG